Anti-tumoral effects of novel lymphatic delivery of anti-CTLA-4 in a metastatic murine breast cancer model

被引：0
|
作者：
Kwon, Sunkuk [1 ]
Velasquez, Fred Christian [1 ]
Ross, Russel F. [2 ]
Hwu, Wen-Jen [3 ]
Sevick-Muraca, Eva M. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Kimberly Clark Inc, Roswell, GA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-LB-005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-005
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Anti-tumoral effects following Ad-mediated delivery of angiogenesis inhibitors
    Perricaudet, M
    Li, H
    Griscelli, F
    Opolon, P
    Soria, J
    Soria, C
    Lu, H
    Yeh, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S225 - S225
  • [32] Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma
    Kaehler, Katharina C.
    Hassel, Jessica C.
    Heinzerling, Lucie
    Loquai, Carmen
    Moessner, Rotraut
    Ugurel, Selma
    Zimmer, Lisa
    Gutzmer, Ralf
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (07): : 662 - 681
  • [33] The anti-tumoral effects of the oxygen carrier YQ23 in a triple-negative breast cancer syngeneic model
    Chow, Elysian
    Lau, Jonathan S. H.
    Wai, Terence
    Lam, Ian P. Y.
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (02) : 656 - 668
  • [34] Melatonin Enhances Anti-tumoral Effects of Menadione on Colon Cancer Cells
    Collin, Alejandro
    Kohan, Romina
    de Talamoni, Nori Tolosa
    Picotto, Gabriela
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (13) : 2411 - 2418
  • [35] How Does an Anti-CTLA-4 Antibody Promote Cancer Immunity?
    Liu, Yang
    Zheng, Pan
    TRENDS IN IMMUNOLOGY, 2018, 39 (12) : 953 - 956
  • [36] Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth
    Ekiz, Huseyin Atakan
    Lai, Shu-Chin Alicia
    Gundlapalli, Harika
    Haroun, Fadi
    Williams, Matthew A.
    Welm, Alana L.
    ONCOIMMUNOLOGY, 2018, 7 (09):
  • [37] SORAFENIB ENHANCES THE ANTI-TUMOR EFFECT OF ANTI-CTLA-4 ANTIBODY TO KIDNEY CANCER
    Takanobu, Motoshima
    Yoshihiro, Komohara
    Yoshiaki, Kawano
    Yoshihiro, Wada
    Masatoshi, Eto
    JOURNAL OF UROLOGY, 2013, 189 (04): : E66 - E66
  • [38] Brief Communication on Pathologic Assessment of Persistent Stable Metastatic Lesions in Patients Treated With Anti-CTLA-4 or Anti-CTLA-4+Anti-PD-1 Therapy
    Buchbinder, Elizabeth. I. I.
    Pfaff, Kathleen. L. L.
    Turner, Madison. M. M.
    Manos, Michael
    Ouyang, Olivia
    Ott, Patrick. A. A.
    Giobbie-Hurder, Anita
    Rodig, Scott. J. J.
    Hodi, F. Stephen
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (05) : 192 - 196
  • [39] Intratumoral Anti-CTLA-4 Blockade Can Potentiate Radiation-Induced Anti-Tumor Immunity In Breast Cancer
    Pilones, K. A.
    Golden, E. B.
    Kraynak, J.
    Formenti, S. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E537 - E537
  • [40] Effects of Combination of Anti-CTLA-4 and Anti-PD-1 on Gastric Cancer Cells Proliferation, Apoptosis and Metastasis
    Wang, Bin
    Qin, Lei
    Ren, Mei
    Sun, Hao
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (01) : 260 - 270
12345